Literature DB >> 27623128

The Impact of Postoperative Complications on a Timely Return to Intended Oncologic Therapy (RIOT): the Role of Enhanced Recovery in the Cancer Journey.

Bradford J Kim1, Abigail S Caudle, Vijaya Gottumukkala, Thomas A Aloia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27623128     DOI： 10.1097/AIA.0000000000000113

Source DB:  PubMed          Journal:  Int Anesthesiol Clin        ISSN： 0020-5907


× No keyword cloud information.
  20 in total

Review 1.  Enhanced recovery after pulmonary surgery.

Authors:  Jules Eustache; Lorenzo E Ferri; Liane S Feldman; Lawrence Lee; Jonathan D Spicer
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

2.  Detours on the Road to Recovery: What Factors Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection for Malignancy?

Authors:  Heather A Lillemoe; Rebecca K Marcus; Bradford J Kim; Nisha Narula; Catherine H Davis; Thomas A Aloia
Journal:  J Gastrointest Surg       Date:  2019-02-26       Impact factor: 3.452

3.  Determining the Safety and Efficacy of Enhanced Recovery Protocols in Major Oncologic Surgery: An Institutional NSQIP Analysis.

Authors:  Rebecca K Marcus; Heather A Lillemoe; David C Rice; Gabriel Mena; Brian K Bednarski; Barbra B Speer; Pedro T Ramirez; Javier D Lasala; Neema Navai; Wendell H Williams; Bradford J Kim; Rachel K Voss; Vijaya N Gottumukkala; Thomas A Aloia
Journal:  Ann Surg Oncol       Date:  2019-01-09       Impact factor: 5.344

4.  Benchmarking Perioperative Outcomes of Cytoreductive Surgery for Cancer: Implications for Quality Measurement.

Authors:  Jason B Liu; Darryl Schuitevoerder; Charles C Vining; Yaniv Berger; Kiran K Turaga; Oliver S Eng
Journal:  Ann Surg Oncol       Date:  2020-07-29       Impact factor: 5.344

5.  Severe Preoperative Symptoms Delay Readiness to Return to Intended Oncologic Therapy (RIOT) After Liver Resection.

Authors:  Heather A Lillemoe; Rebecca K Marcus; Bradford J Kim; Nisha Narula; Catherine H Davis; Qiuling Shi; Xin Shelley Wang; Thomas A Aloia
Journal:  Ann Surg Oncol       Date:  2019-08-14       Impact factor: 5.344

Review 6.  The implementation of enhanced recovery after surgery protocols in ovarian malignancy surgery.

Authors:  Joseph J Noh; Myeong-Seon Kim; Yoo-Young Lee
Journal:  Gland Surg       Date:  2021-03

7.  Completion of adjuvant therapy in patients with resected pancreatic cancer.

Authors:  Danielle K DePeralta; Takuya Ogami; Jun-Min Zhou; Michael J Schell; Benjamin D Powers; Pamela J Hodul; Mokenge P Malafa; Jason B Fleming
Journal:  HPB (Oxford)       Date:  2019-09-25       Impact factor: 3.647

8.  Physical activity and exercise during preoperative pancreatic cancer treatment.

Authors:  Nathan H Parker; An Ngo-Huang; Rebecca E Lee; Daniel P O'Connor; Karen M Basen-Engquist; Maria Q B Petzel; Xuemei Wang; Lianchun Xiao; David R Fogelman; Keri L Schadler; Richard J Simpson; Jason B Fleming; Jeffrey E Lee; Gauri R Varadhachary; Sunil K Sahai; Matthew H G Katz
Journal:  Support Care Cancer       Date:  2018-10-17       Impact factor: 3.603

9.  Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.

Authors:  Lawrence Lee; Nathalie Wong-Chong; Justin J Kelly; George J Nassif; Matthew R Albert; John R T Monson
Journal:  Surg Endosc       Date:  2018-07-02       Impact factor: 4.584

10.  Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery.

Authors:  Jose M Soliz; Ifeyinwa C Ifeanyi; Mathew H Katz; Jonathan Wilks; Juan P Cata; Thomas McHugh; Jason B Fleming; Lei Feng; Thomas Rahlfs; Morgan Bruno; Vijaya Gottumukkala
Journal:  Anesth Pain Med       Date:  2017-08-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.